Correlation Between Ayala Pharmaceuticals and Sage Therapeutic

Can any of the company-specific risk be diversified away by investing in both Ayala Pharmaceuticals and Sage Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ayala Pharmaceuticals and Sage Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ayala Pharmaceuticals and Sage Therapeutic, you can compare the effects of market volatilities on Ayala Pharmaceuticals and Sage Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ayala Pharmaceuticals with a short position of Sage Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ayala Pharmaceuticals and Sage Therapeutic.

Diversification Opportunities for Ayala Pharmaceuticals and Sage Therapeutic

0.0

Correlation Coefficient

Ayala Pharmaceuticals  Sage Therapeutic

Pay attention - limited upside

The 3 months correlation between Ayala and Sage is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ayala Pharmaceuticals and Sage Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sage Therapeutic and Ayala Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ayala Pharmaceuticals are associated (or correlated) with Sage Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sage Therapeutic has no effect on the direction of Ayala Pharmaceuticals i.e., Ayala Pharmaceuticals and Sage Therapeutic go up and down completely randomly.

Pair Corralation between Ayala Pharmaceuticals and Sage Therapeutic

If you would invest  579.00  in Sage Therapeutic on December 1, 2024 and sell it today you would earn a total of  140.00  from holding Sage Therapeutic or generate 24.18% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Ayala Pharmaceuticals  vs.  Sage Therapeutic

Ayala Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ayala Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ayala Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Sage Therapeutic

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sage Therapeutic are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Sage Therapeutic exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ayala Pharmaceuticals and Sage Therapeutic

The main advantage of trading using opposite Ayala Pharmaceuticals and Sage Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ayala Pharmaceuticals position performs unexpectedly, Sage Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sage Therapeutic will offset losses from the drop in Sage Therapeutic's long position.

The idea behind Ayala Pharmaceuticals and Sage Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.